The Addition of Rituximab to CHOP Chemotherapy Improves Response Rate, Failure-Free Survival and Overall Survival for Follicular Grade 3 Lymphoma Compared to CHOP Alone
暂无分享,去创建一个
P. Mclaughlin | F. Cabanillas | M. Overman | A. Younes | L. Kwak | L. Fayad | F. Hagemeister | B. Pro | M. Hess | J. Romaguera | F. Samaniego | M. Rodriguez | Lei Feng